| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | NEUTRAL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.12▲ | 7.18▼ | 7.18▼ | 7.13▼ | 7.00▲ |
| MA10 | 7.15▲ | 7.20▼ | 7.20▼ | 7.00▲ | 7.15▼ |
| MA20 | 7.18▼ | 7.11▲ | 7.11▲ | 6.98▲ | N/A |
| MA50 | 7.09▲ | 6.95▲ | 6.99▲ | 7.28▼ | N/A |
| MA100 | 6.96▲ | 7.05▲ | 7.05▲ | N/A | N/A |
| MA200 | 7.04▲ | 7.19▼ | 7.40▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.017▼ | -0.007▼ | -0.007▼ | 0.074▲ | N/A |
| RSI | 53.874▲ | 54.181▲ | 53.390▲ | 49.529▼ | N/A |
| STOCH | 23.909 | 52.591 | 52.806 | 71.111 | N/A |
| WILL %R | -50.000 | -54.286 | -28.358 | -29.630 | -76.687▼ |
| CCI | -18.795 | -125.152▼ | -67.837 | 49.101 | -53.851 |
|
Friday, April 10, 2026 01:10 PM
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective ...
|
|
Friday, April 10, 2026 08:36 AM
An announcement from Kyntra Bio ( (KYNB) ) is now available.
|
|
Wednesday, April 08, 2026 02:20 PM
Kyntra Bio (Nasdaq: KYNB) today announced that the Company will present at the 25th Annual Needham Virtual Healthcare Conference being held April 13-16, 2026. Thane Wettig, Chief Executive Officer of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/04/26 | 7.05 | 7.18 | 7.03 | 7.08 | 28,264 |
| 10/04/26 | 7.22 | 7.22 | 7.10 | 7.17 | 4,135 |
| 09/04/26 | 7.145 | 7.30 | 7.145 | 7.19 | 12,257 |
| 08/04/26 | 7.34 | 7.34 | 7.175 | 7.30 | 11,037 |
| 07/04/26 | 6.95 | 7.16 | 6.82 | 6.92 | 36,633 |
| 06/04/26 | 7.24 | 7.24 | 6.98 | 6.98 | 5,798 |
| 02/04/26 | 7.25 | 7.40 | 7.01 | 7.01 | 11,546 |
| 01/04/26 | 6.86 | 7.35 | 6.835 | 7.10 | 30,726 |
| 31/03/26 | 6.635 | 6.94 | 6.60 | 6.78 | 23,728 |
| 30/03/26 | 6.5532 | 6.59 | 6.32 | 6.46 | 49,175 |
|
|
||||
|
|
||||
|
|